Zhou Bo-Wen, Liu Hua-Man, Jia Xin-Hua
Shandong University of Traditional Chinese Medicine, Jinan, China.
Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Pharmacol. 2022 Jul 15;13:917256. doi: 10.3389/fphar.2022.917256. eCollection 2022.
Asthma as an individual disease has blighted human health for thousands of years and is still a vital global health challenge at present. Though getting much progress in the utilization of antibiotics, mucolytics, and especially the combination of inhaled corticosteroids (ICS) and long-acting β-agonists (LABA), we are confused about the management of asthmatic airway inflammation and remodeling, which directly threatens the quality of life for chronic patients. The blind addition of ICS will not benefit the remission of cough, wheeze, or sputum, but to increase the risk of side effects. Thus, it is necessary to explore an effective therapy to modulate asthmatic inflammation and airway remodeling. Traditional Chinese Medicine (TCM) has justified its anti-asthma effect in clinical practice but its underlying mechanism and specific role in asthma are still unknown. Some animal studies demonstrated that the classic formula, direct exacts, and natural compounds isolated from TCM could significantly alleviate airway structural alterations and exhibit the anti-inflammatory effects. By investigating these findings and data, we will discuss the possible pathomechanism underlined airway inflammation and remodeling in asthma and the unique role of TCM in the treatment of asthma through regulating different signaling pathways.
哮喘作为一种独立的疾病,已经困扰人类健康数千年,目前仍然是一项重大的全球健康挑战。尽管在抗生素、黏液溶解剂,尤其是吸入性糖皮质激素(ICS)和长效β受体激动剂(LABA)联合使用方面取得了很大进展,但我们对哮喘气道炎症和重塑的管理仍感到困惑,这直接威胁到慢性病患者的生活质量。盲目添加ICS并不能使咳嗽、喘息或咳痰得到缓解,反而会增加副作用的风险。因此,有必要探索一种有效的疗法来调节哮喘炎症和气道重塑。中医在临床实践中已证明其抗哮喘作用,但其潜在机制以及在哮喘中的具体作用仍不明确。一些动物研究表明,从中医中分离出的经典方剂、直接提取物和天然化合物可以显著减轻气道结构改变,并发挥抗炎作用。通过研究这些发现和数据,我们将探讨哮喘气道炎症和重塑背后可能的发病机制,以及中医通过调节不同信号通路在哮喘治疗中的独特作用。